Correlation Between Unicycive Therapeutics and Biodexa Pharmaceticals
Can any of the company-specific risk be diversified away by investing in both Unicycive Therapeutics and Biodexa Pharmaceticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unicycive Therapeutics and Biodexa Pharmaceticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Unicycive Therapeutics and Biodexa Pharmaceticals, you can compare the effects of market volatilities on Unicycive Therapeutics and Biodexa Pharmaceticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unicycive Therapeutics with a short position of Biodexa Pharmaceticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unicycive Therapeutics and Biodexa Pharmaceticals.
Diversification Opportunities for Unicycive Therapeutics and Biodexa Pharmaceticals
-0.6 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Unicycive and Biodexa is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding Unicycive Therapeutics and Biodexa Pharmaceticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biodexa Pharmaceticals and Unicycive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unicycive Therapeutics are associated (or correlated) with Biodexa Pharmaceticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biodexa Pharmaceticals has no effect on the direction of Unicycive Therapeutics i.e., Unicycive Therapeutics and Biodexa Pharmaceticals go up and down completely randomly.
Pair Corralation between Unicycive Therapeutics and Biodexa Pharmaceticals
Given the investment horizon of 90 days Unicycive Therapeutics is expected to generate 0.89 times more return on investment than Biodexa Pharmaceticals. However, Unicycive Therapeutics is 1.13 times less risky than Biodexa Pharmaceticals. It trades about 0.23 of its potential returns per unit of risk. Biodexa Pharmaceticals is currently generating about -0.1 per unit of risk. If you would invest 51.00 in Unicycive Therapeutics on August 31, 2024 and sell it today you would earn a total of 17.00 from holding Unicycive Therapeutics or generate 33.33% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Unicycive Therapeutics vs. Biodexa Pharmaceticals
Performance |
| Timeline |
| Unicycive Therapeutics |
| Biodexa Pharmaceticals |
Unicycive Therapeutics and Biodexa Pharmaceticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Unicycive Therapeutics and Biodexa Pharmaceticals
The main advantage of trading using opposite Unicycive Therapeutics and Biodexa Pharmaceticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unicycive Therapeutics position performs unexpectedly, Biodexa Pharmaceticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biodexa Pharmaceticals will offset losses from the drop in Biodexa Pharmaceticals' long position.| Unicycive Therapeutics vs. Cue Biopharma | Unicycive Therapeutics vs. Eliem Therapeutics | Unicycive Therapeutics vs. Inhibrx | Unicycive Therapeutics vs. Molecular Partners AG |
| Biodexa Pharmaceticals vs. Pintec Technology Holdings | Biodexa Pharmaceticals vs. Senmiao Technology | Biodexa Pharmaceticals vs. Mill City Ventures | Biodexa Pharmaceticals vs. Western Digital |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |